IBDT:NYE-iShares iBonds Dec 2028 Term Corporate ETF (USD)

ETF | Target Maturity |

Last Closing

USD 25.01

Change

0.00 (0.00)%

Market Cap

USD 2.30B

Volume

0.30M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The fund will invest at least 80% of its assets in the component instruments of the underlying index and will invest at least 90% of its assets in fixed income securities of the types included in the underlying index. The index consists of U.S. dollar-denominated, investment-grade securities publicly issued by U.S. and non-U.S. corporate issuers that have $300 million or more of outstanding face value at the time of inclusion.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-13 )

Largest Industry Peers for Target Maturity

Symbol Name Price(Change) Market Cap
IBDR iShares iBonds Dec 2026 Term C..

+0.02 (+0.08%)

USD 2.95B
IBDQ iShares iBonds Dec 2025 Term C..

+0.01 (+0.04%)

USD 2.88B
IBDS iShares iBonds Dec 2027 Term C..

+0.01 (+0.04%)

USD 2.61B
IBDP iShares iBonds Dec 2024 Term C..

-0.01 (-0.04%)

N/A

ETFs Containing IBDT

N/A

Market Performance

  Market Performance vs. Industry/Classification (Target Maturity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.32% 20% F 28% F
Dividend Return 3.85% 100% F 60% D-
Total Return 3.53% 20% F 29% F
Trailing 12 Months  
Capital Gain 3.43% 100% F 28% F
Dividend Return 4.78% 100% F 60% D-
Total Return 8.21% 100% F 29% F
Trailing 5 Years  
Capital Gain -9.55% 20% F 33% F
Dividend Return 16.32% 100% F 53% F
Total Return 6.77% 20% F 31% F
Average Annual (5 Year Horizon)  
Capital Gain -2.86% 60% D- 21% F
Dividend Return -0.19% 60% D- 21% F
Total Return 2.67% 100% F 59% D-
Risk Return Profile  
Volatility (Standard Deviation) 6.80% 60% D- 87% B+
Risk Adjusted Return -2.86% 60% D- 21% F
Market Capitalization 2.30B 25% F 68% D+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.